INCB000928

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
272	進行性骨化性線維異形成症	3

272. 進行性骨化性線維異形成症

臨床試験数 : 39 / 薬物数 : 38 - (DrugBank : 7) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 95

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05090891 (ClinicalTrials.gov)	May 5, 2022	8/10/2021	To Assess the Efficacy, Safety, and Tolerability of INCB000928in Participants With Fibrodysplasia Os ...	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and ...	Fibrodysplasia Ossificans Progressiva (FOP)	Drug: INCB000928;Drug: placebo	Incyte Corporation	NULL	Recruiting	12 Years	99 Years	All	60	Phase 2	United States;Australia;Brazil;Canada;Chile;China;France;Germany;Italy;Korea, Republic of;Mexico;Net ...
2	EUCTR2021-002286-17-FR (EUCTR)	19/04/2022	22/10/2021	A Phase 2, Randomized Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928in Parti ...	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study toEvaluate the Efficacy, Safety, and T ...	Fibrodysplasia ossificans progressiva MedDRA version: 20.0;Level: PT;Classification code 10068715;Te ...	Product Code: INCB000928 Other descriptive name: INCB000928 fumarate dihydrate	Incyte Corporation	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 2	United States;France;Canada;Brazil;Australia;Russian Federation;Netherlands;Germany;United Kingdom;K ...
3	EUCTR2021-002286-17-DE (EUCTR)		04/11/2021	A Phase 2, Randomized Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928in Parti ...	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study toEvaluate the Efficacy, Safety, and T ...	Fibrodysplasia ossificans progressiva MedDRA version: 20.0;Level: PT;Classification code 10068715;Te ...	Product Code: INCB000928 Other descriptive name: INCB000928 fumarate dihydrate	Incyte Corporation	NULL	NA			Female: yes Male: yes	60	Phase 2	France;United States;Canada;Brazil;Australia;Russian Federation;Netherlands;Germany;United Kingdom;K ...

First Previous1Next Last